CMS requires Part D plans to perform retrospective drug utilization review (DUR) analysis to identify prior inappropriate or unnecessary medication use and provide education, such as alert letters, to the prescribers involved.
What does RDUR stand for?
RDUR stands for Retrospective Drug Utilization Review
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Organizations, NGOs, schools, universities, etc.
- Remote Display Unit
- Renal Dialysis Unit
- Reptiles Down Under (Australia)
- Restricted Duties
- Random Delay with Uniform Distribution
- Research and Development Unit for English Studies
- Reference Data User Group
- Raw Data User Manual
- Rally for Democracy and Unity
- Rural Development, Utilities Programs (USDA)
Samples in periodicals archive:
Conducting Retrospective Drug Utilization Reviews and Clinical Intervention Programs ** Retrospective reviews involve pharmacy benefit manager clinical pharmacist teams auditing prescriptions that have been filled for indicators of inappropriate use such as sole use of narcotics as treatment, multiple physicians, use of multiple short- or long-acting narcotics or excessive duration and use.
Researchers from Prime and one of its Blue Cross and Blue Shield clients used a retrospective drug utilization review to analyze claims data from a 1.
April 14 /PRNewswire/ -- Research conducted by Prime Therapeutics (Prime) revealed a significant reduction in inappropriate prescription medication use among older adults when a retrospective drug utilization review (RetroDUR) program paired with a provider intervention initiative was implemented.
org will experience new features, including how to use the information for claims processing, retrospective drug utilization review (RDUR) and ePrescribing, as well as the unique feature on a National Provider Identifier (NPI) and Drug Enforcement Administration (DEA) number "crosswalk"--the ability to verify and cross-reference both essential numbers--to streamline the prescriber data verification process.
ACS has also provided MO HealthNet with Retrospective Drug Utilization review and academic detailing programs that have enabled the state to save more than $10 million.
Sixty-eight percent of respondents also use retrospective Drug Utilization Reviews (up from 55 percent in 2004).
SXC's services will include claims processing, prospective and retrospective Drug Utilization Review (DUR) and DUR Board support, clinical program/utilization management that includes prior authorization services and Preferred Drug List (PDL) support, provider call centers, DCH retail pharmacy network administration, fraud and abuse services, and ad hoc and standard reporting systems.